Chemoinformaics analysis of BETA-URSOLIC-ACID
Molecular Weight | 455.703 | nRot | 1 |
Heavy Atom Molecular Weight | 408.327 | nRig | 27 |
Exact Molecular Weight | 455.353 | nRing | 5 |
Solubility: LogS | -4.383 | nHRing | 0 |
Solubility: LogP | 6.083 | No. of Aliphatic Rings | 5 |
Acid Count | 1 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
Atoms Count | 80 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 33 | No. of Aromatic Carbocycles | 0 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 4 |
No. of Hydrogen atom | 47 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 30 | No. of Saturated Rings | 4 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
nHA | 3 | APOL | 83.8453 |
nHD | 1 | BPOL | 48.8867 |
QED | 0.414 |
Synth | 4.723 |
Natural Product Likeliness | 3.186 |
NR-PPAR-gamma | 0.89 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.001 |
Pgp-sub | 0 |
HIA | 0.011 |
CACO-2 | -5.221 |
MDCK | 0.0000139 |
BBB | 0.719 |
PPB | 0.988431 |
VDSS | 0.815 |
FU | 0.0224174 |
CYP1A2-inh | 0.008 |
CYP1A2-sub | 0.434 |
CYP2c19-inh | 0.018 |
CYP2c19-sub | 0.95 |
CYP2c9-inh | 0.113 |
CYP2c9-sub | 0.701 |
CYP2d6-inh | 0.002 |
CYP2d6-sub | 0.276 |
CYP3a4-inh | 0.137 |
CYP3a4-sub | 0.404 |
CL | 3.671 |
T12 | 0.017 |
hERG | 0.001 |
Ames | 0.012 |
ROA | 0.183 |
SkinSen | 0.013 |
Carcinogencity | 0.031 |
EI | 0.137 |
Respiratory | 0.968 |
NR-Aromatase | 0.817 |
Antiviral | No |
Prediction | 0.720969 |